Home

Lineage, Inc. - Common Stock (LINE)

41.64
-1.16 (-2.71%)
NASDAQ · Last Trade: Aug 10th, 1:46 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close42.80
Open43.18
Bid40.29
Ask42.46
Day's Range41.54 - 44.60
52 Week Range40.49 - 88.57
Volume1,702,842
Market Cap9.54B
PE Ratio (TTM)-15.89
EPS (TTM)-2.6
Dividend & Yield2.112 (5.07%)
1 Month Average Volume1,170,520

Chart

About Lineage, Inc. - Common Stock (LINE)

Lineage, Inc. is a biotech company focused on advancing regenerative medicine and developing therapeutic solutions for patients with degenerative diseases and injuries. The company utilizes innovative technologies, including stem cell research and tissue engineering, to create treatments aimed at restoring function and improving quality of life. Through its research and development efforts, Lineage seeks to bring groundbreaking therapies to market, addressing unmet medical needs in various fields such as ophthalmology, neurology, and orthopedics. By leveraging scientific advancements and collaborative partnerships, Lineage continues to work towards its mission of transforming medicine and enhancing patient outcomes. Read More

News & Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 9, 2025
LINE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Lineage, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 8, 2025
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Lineage, Inc. (LINE) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company’s July 2024 initial public offering (the “IPO”). Lineage investors have until September 30, 2025 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · August 8, 2025
Analyst Expectations For Lineage's Futurebenzinga.com
Via Benzinga · August 7, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
Lineage, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LINE
NEW YORK - August 8, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Lineage, Inc. (NASDAQ: LINE) of a class action securities lawsuit.
Via TheNewswire.com · August 8, 2025
Lineage, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LINE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 8, 2025
Law Offices of Howard G. Smith Encourages Lineage, Inc. (LINE) Investors To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement used in connection with the Company’s July 2024 initial public offering (the “IPO”). Lineage investors have until September 30, 2025 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · August 7, 2025
Lineage, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LINE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 7, 2025
Lineage, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LINE
NEW YORK - August 7, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Lineage, Inc. (NASDAQ: LINE) of a class action securities lawsuit.
Via TheNewswire.com · August 7, 2025
LINEAGE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - LINE
Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with Lineage’s July 2024 initial public offering (“IPO”), have until September 30, 2025 to seek appointment as lead plaintiff of the Lineage class action lawsuit. Captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., No. 25-cv-12383 (E.D. Mich.), the Lineage class action lawsuit charges Lineage as well as certain of its top executives, directors, IPO underwriters, and IPO sponsor with violations of the Securities Act of 1933.
Lineage, Inc. Reports Second-Quarter 2025 Financial Results
Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world’s largest global temperature-controlled warehouse REIT, today announced its financial results for the second quarter of 2025.
By Lineage, Inc. · Via Business Wire · August 6, 2025
Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of Linage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with the Company's 2024 initial public offering ("IPO"). Lineage is a Maryland REIT focused on temperature-controlled cold-manage facilities.
By Robbins LLP · Via GlobeNewswire · August 5, 2025
LINEAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lineage, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lineage (LINE) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · August 5, 2025
LINE BREAKING NEWS: Lineage, Inc. Stock Significantly Declines After IPO on Customer Downturn -- Investors with Losses are Notified to Contact BFA Law before September 30 Class Action Deadline
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · August 5, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 5, 2025
LINEAGE, INC. (NASDAQ: LINE) INVESTOR ALERT – Investors With Large Losses in Lineage, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) in, or traceable to, the registration statement issued in connection with the Company’s July 2024 initial public offering (the “IPO”).
By Bernstein Liebhard LLP · Via GlobeNewswire · August 4, 2025
LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of the federal securities laws.
By The Schall Law Firm · Via Business Wire · August 3, 2025
LINEAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead the Lineage Class Action Lawsuit – LINE
Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or traceable to the registration statement used in connection with Lineage’s July 2024 initial public offering (the “IPO”), have until September 30, 2025 to seek appointment as lead plaintiff of the Lineage class action lawsuit. Captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., No. 25-cv-12383 (E.D. Mich.), the Lineage class action lawsuit charges Lineage and certain of its top executives, directors, IPO underwriters, and IPO sponsor with violations of the Securities Act of 1933.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · August 1, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 28, 2025
Bragar Eagel & Squire, P.C Continues Investigations on Behalf of Lineage, Proficient Auto, PetMed, and GeneDx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS), GeneDx (WGS), Lineage (LINE), or Proficient Auto (PAL) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 23, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 23, 2025
What 12 Analyst Ratings Have To Say About Lineagebenzinga.com
Via Benzinga · July 21, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE
NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · July 18, 2025